Aytu Biopharma (AYTU) Other Accumulated Expenses (2012 - 2026)
Aytu Biopharma's Other Accumulated Expenses was $1.3 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 61.7% from $3.38 million a year earlier and down 41.1% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
From fiscal Q4 2012 onward, Aytu Biopharma has reported Other Accumulated Expenses for 33 quarters.
- Other Accumulated Expenses shows a five-year compound annual growth rate of -31.1% (FY2021 to FY2026).
- In earlier fiscal years, Other Accumulated Expenses was $3.38 million in FY2025 (-62.3%), $8.96 million in FY2024 (+26.4%), $7.09 million in FY2023 (+32.3%) and $5.36 million in FY2022 (-35.8%).
- The fiscal Q4 2026 figure marks the lowest quarterly Other Accumulated Expenses since fiscal Q1 2021.
- Compared with a year earlier, Other Accumulated Expenses has declined for eight straight quarters, with an average decline of 49.3% over the last eight quarters.
- The best year-over-year quarter for Other Accumulated Expenses over five years was fiscal Q1 2022 (growth of 370.4%); the worst was fiscal Q1 2026 (a decline of 75.1%).
- Per Business Quant data, AYTU's Other Accumulated Expenses in the three fiscal quarters before Q4 2026 was $2.2 million (Q3 2026), $2.92 million (Q2 2026) and $1.97 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 8.96 Mn |
| Mar 31, 2024 | 9.15 Mn |
| Dec 31, 2023 | 9.24 Mn |
| Sep 30, 2023 | 8.99 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 7.45 Mn |
| Dec 31, 2022 | 7.83 Mn |
| Sep 30, 2022 | 8.09 Mn |
| Jun 30, 2022 | 5.36 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.17 Mn |
| Sep 30, 2021 | 3.19 Mn |
API Access
Aytu Biopharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();